Clinical Trial Update: Head-to-Head Study of Etelcalcetide and Cinacalcet in Asian Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT) [Phase 3]

View source ↗

Summary

Phase 3 head-to-head trial comparing etelcalcetide with cinacalcet in Asian hemodialysis patients with secondary hyperparathyroidism has completed, with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperparathyroidism

Drugs mentioned

• Etelcalcetide (etelcalcetide)
• cinacalcet (cinacalcet hydrochloride)

Snippet

Sponsor: Amgen | Conditions: Secondary Hyperparathyroidism, Chronic Kidney Disease | Phase 3 | Status: COMPLETED | Results posted: 2021-04-30